Ergosta-7,22-diene-2β,3α,9α-triol from the fruit bodies of Ganoderma lucidum induces apoptosis in human myelocytic HL-60 cells

Phytother Res. 2011 Nov;25(11):1579-85. doi: 10.1002/ptr.3447. Epub 2011 Mar 11.

Abstract

Ganoderma lucidum is known as a medicinal mushroom used in traditional medicine. In our study, the cytotoxic activities of 17 compounds (1-17) isolated from the fruiting bodies of G. lucidum were investigated. Among them, ergosta-7,22-diene-2β,3α,9α-triol (EGDT) induced apoptosis in HL-60 human premyelocytic leukemia cells. EGDT activated the apoptotic process, including DNA fragmentation and caspase-3 activity. In immunoblotting analysis, treatment with EGDT resulted in the cleavage of procaspase-3 and poly(ADP-ribose) polymerase (PARP) into active forms. In the in vivo study, the administration (i.p.) of EGDT to Lewis lung carcinoma (LLC)-inoculated mice evidenced a significant inhibition of tumor growth. These results indicate that EGDT was one of the apoptotic constituents of G. lucidum, and might be an antitumor agent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Apoptosis / drug effects*
  • Carcinoma, Lewis Lung / drug therapy
  • Caspase 3 / metabolism
  • DNA Fragmentation
  • Female
  • HL-60 Cells / drug effects
  • Humans
  • Mice
  • Phytosterols / pharmacology*
  • Reishi / chemistry*

Substances

  • Antineoplastic Agents, Phytogenic
  • Phytosterols
  • cerevisterol
  • CASP3 protein, human
  • Caspase 3